These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 37430160)

  • 1. Prognostic significance of post-preoperative tumor markers increments in patients with non-metastatic gastric cancer.
    Zhu XD; Zhang LX; Luo PQ; Zhu H; Wei ZJ; Xu AM
    J Cancer Res Clin Oncol; 2023 Oct; 149(13):12191-12201. PubMed ID: 37430160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preoperative Tumor Markers Independently Predict Survival in Stage III Gastric Cancer Patients: Should We Include Tumor Markers in AJCC Staging?
    Lin JX; Wang W; Lin JP; Xie JW; Wang JB; Lu J; Chen QY; Cao LL; Lin M; Tu R; Zheng CH; Huang CM; Zhou ZW; Li P
    Ann Surg Oncol; 2018 Sep; 25(9):2703-2712. PubMed ID: 29971670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic Value of Combination of Inflammatory and Tumor Markers in Resectable Gastric Cancer.
    Guo L; Wang Q; Chen K; Liu HP; Chen X
    J Gastrointest Surg; 2021 Oct; 25(10):2470-2483. PubMed ID: 33575904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of preoperative serum CA125, CA19-9 and CEA in gastric carcinoma.
    Wang W; Chen XL; Zhao SY; Xu YH; Zhang WH; Liu K; Chen XZ; Yang K; Zhang B; Chen ZX; Chen JP; Zhou ZG; Hu JK
    Oncotarget; 2016 Jun; 7(23):35423-36. PubMed ID: 27097114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamic monitoring of serum CEA and CA19-9 predicts the prognosis of postoperative stage II colon cancer.
    Wang R; Xu B; Sun M; Pang X; Wang X; Zhu J; Lian J; Lu H
    Eur J Surg Oncol; 2023 Dec; 49(12):107138. PubMed ID: 37925830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined detection of preoperative serum CEA, CA19-9 and CA242 improve prognostic prediction of surgically treated colorectal cancer patients.
    Wang J; Wang X; Yu F; Chen J; Zhao S; Zhang D; Yu Y; Liu X; Tang H; Peng Z
    Int J Clin Exp Pathol; 2015; 8(11):14853-63. PubMed ID: 26823815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical assessment and prognostic evaluation of tumor markers in patients with gastric cancer.
    Jiexian J; Xiaoqin X; Lili D; Baoguo T; Ting S; Xianwen Z; Cunzhi H
    Int J Biol Markers; 2013 Jun; 28(2):192-200. PubMed ID: 23787496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of tumor marker regression load score on long-term prognosis of gastric cancer patients undergoing radical surgery after neoadjuvant chemotherapy.
    Zhang LK; Zheng HL; Zheng HH; Ma YB; Lin JX; Xu BB; Xue Z; Zheng ZW; Zheng CH; Huang CM; Xie JW
    Eur J Surg Oncol; 2024 Jun; 50(6):108367. PubMed ID: 38718701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of pre- and post-operative tumour markers for patients with gastric cancer.
    Lin JP; Lin JX; Ma YB; Xie JW; Yan S; Wang JB; Lu J; Chen QY; Ma XF; Cao LL; Lin M; Tu RH; Zheng CH; Li P; Huang CM
    Br J Cancer; 2020 Aug; 123(3):418-425. PubMed ID: 32451469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of serum and gastric juice levels of carcinoembryonic antigen, CA19.9 and CA72.4 in patients with gastric cancer.
    Tocchi A; Costa G; Lepre L; Liotta G; Mazzoni G; Cianetti A; Vannini P
    J Cancer Res Clin Oncol; 1998; 124(8):450-5. PubMed ID: 9750022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative serum carbohydrate antigen 125 level is an independent negative prognostic marker for overall survival in colorectal cancer.
    Yang XQ; Li Y; Chen C; Peng CW; Liu SP; Liu Y
    Med Oncol; 2011 Sep; 28(3):789-95. PubMed ID: 20373053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CA19-9 is a significant prognostic marker of patients with stage III gastric cancer.
    Kambara Y; Miyake H; Nagai H; Yoshioka Y; Shibata K; Asai S; Yuasa N
    Eur J Surg Oncol; 2020 Oct; 46(10 Pt A):1918-1924. PubMed ID: 32814681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical importance of preoperative carcinoembryonic antigen and carbohydrate antigen 19-9 levels in gastric cancer.
    Ishigami S; Natsugoe S; Hokita S; Che X; Tokuda K; Nakajo A; Iwashige H; Tokushige M; Watanabe T; Takao S; Aikou T
    J Clin Gastroenterol; 2001 Jan; 32(1):41-4. PubMed ID: 11154168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prognostic value of carcinoembryonic antigen, alpha fetoprotein, carbohydrate antigen 125 and carbohydrate antigen 19-9 in gastroenteropancreatic neuroendocrine neoplasms].
    Chen L; Zhang Y; Chen M; Chen J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Sep; 20(9):1002-1008. PubMed ID: 28900990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of dynamic changes of pre- and post-operative tumor markers in colorectal cancer.
    Ren G; Zheng G; Du K; Dang Z; Dan H; Dou X; Duan L; Xie Z; Niu L; Tian Y; Zheng J; Feng F
    Clin Transl Oncol; 2024 Aug; 26(8):2047-2059. PubMed ID: 38453817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor markers for diagnosis, monitoring of recurrence and prognosis in patients with upper gastrointestinal tract cancer.
    Jing JX; Wang Y; Xu XQ; Sun T; Tian BG; Du LL; Zhao XW; Han CZ
    Asian Pac J Cancer Prev; 2014; 15(23):10267-72. PubMed ID: 25556459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Changes and Clinical Significance of Preoperative and Postoperative Serum CEA and CA19-9 in Gastric Cancer.
    Jing R; Cui M; Ju S; Pan S
    Clin Lab; 2020 Apr; 66(4):. PubMed ID: 32255307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical significance and prognostic value of CA72-4 compared with CEA and CA19-9 in patients with gastric cancer.
    Ychou M; Duffour J; Kramar A; Gourgou S; Grenier J
    Dis Markers; 2000; 16(3-4):105-10. PubMed ID: 11381189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CA19‑9 is a significant prognostic factor in stage III gastric cancer patients undergoing radical gastrectomy.
    Ma X; Zhou X; Guo J; Feng X; Zhao M; Zhang P; Zhang C; Gong S; Wu N; Zhang Y; Zhang X; Ren Z; Zhang P
    BMC Surg; 2024 Jan; 24(1):31. PubMed ID: 38263014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic impact of CEA/CA19-9 at the time of recurrence in patients with gastric cancer.
    Moriyama J; Oshima Y; Nanami T; Suzuki T; Yajima S; Shiratori F; Funahashi K; Shimada H
    Surg Today; 2021 Oct; 51(10):1638-1648. PubMed ID: 33682011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.